TMEM119

Transmembrane protein 119

Also known as: TMEM119

Biology & Mechanism

TMEM119 (Transmembrane Protein 119) is renowned as the gold-standard marker for distinguishing brain-resident microglia from infiltrating peripheral macrophages. While macrophages share nearly all the same myeloid machinery (like IBA1, CD68, and ITGAM), TMEM119 is uniquely restricted to the brain-derived microglial lineage under homeostatic conditions.

Despite its ubiquity in microglial research, the precise biological function of TMEM119 remains elusive. Current evidence suggests it is structurally related to cell-surface rigidity or tethering to the extracellular matrix, playing a structural role in maintaining the vast, deeply ramified morphology characteristic of resting microglia.

Similar to P2RY12, TMEM119 expression collapses entirely when microglia enter the pro-inflammatory or Disease-Associated Microglia (DAM) state. Its primary utility in the field remains as a sophisticated molecular beacon: researchers rely on TMEM119 to prove that a therapeutic intervention or transcriptomic signature specifically applies to the endogenous brain-resident immune system rather than peripheral monocytes leaking across a degraded blood-brain barrier.

Open Questions

  • What is the molecular function of TMEM119 in homeostatic microglia?
  • Can TMEM119 loss be used as a reliable biomarker of microglial activation state in vivo?
  • Does TMEM119 expression correlate with neuroprotective microglial function?

Sources

Evidence Status

human tissuesingle-cell RNA-seqanimal model

Disease Links

  • Alzheimer's disease
  • Multiple sclerosis
  • Traumatic brain injury
  • Brain aging

Related Targets

Last reviewed: June 1, 2026